Clinical Trials Logo

Total Joint Arthroplasty clinical trials

View clinical trials related to Total Joint Arthroplasty.

Filter by:

NCT ID: NCT06467721 Not yet recruiting - Clinical trials for Total Joint Arthroplasty

Clinical Efficacy of Self-adhesive Silicone Gel Waterproof Dressings Versus Conventional Dressings in the Healing of Incisions After Total Joint Arthroplasty

Yes
Start date: August 1, 2024
Phase: N/A
Study type: Interventional

The efficacy of using self-adhesive silicone gel waterproof dressings versus conventional gauze dressings for recovery after total joint arthroplasty (TJA) remains unclear. In our study, we conducted a prospective, randomized controlled trial to compare these two types of dressings. Patients were divided into two groups following TJA, and we collected primary outcome measures such as skin infection rate and re-operation rate. Additionally, we gathered blood inflammatory indicators, including C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), to evaluate the effectiveness of the two treatments. Finally, we perform one year follow up including REEDA score, MSS score to evaluate the recovery of the skin.

NCT ID: NCT05858086 Not yet recruiting - Physical Therapy Clinical Trials

Is Physical Therapy Clearance Before Arthroplasty Home Discharge Necessary?

PTClearSHoT
Start date: June 2024
Phase: N/A
Study type: Interventional

Conventionally, physical therapy (PT) clearance is sought before total joint arthroplasty (TJA) discharge. However, PT staffing limitations may preclude same-day discharge in patients having surgery late in the day. Failed same-day discharge in eligible TJA patients results in unnecessary hospital bed occupancy, which increases costs, limits operating room throughput for patients requiring inpatient admission, and introduces risks associated with longer length-of-stay. In collaboration with an institutional PT department, the investigators developed a protocol for discharging same-day TJA patients without postoperative PT clearance. Immediately preoperatively, PT administers gait training. Patients are then discharged home after ambulating with post-anesthesia care unit (PACU) nurses trained by PT on postoperative mobilization. This allows for the maximum number of patients discharged home, including the last patient of the day, PT staffing limitations notwithstanding. Single-institution pilot data demonstrates no increased risk of falls, emergency room (ER) visits, or readmissions with this process. The investigators propose a prospective, controlled, multicenter study to expand on pilot data. The study aim is to assess safety of day-of-surgery preoperative PT and postoperative ambulation with PACU nursing before TJA discharge. The primary endpoint is postoperative falls, while secondary endpoints include 90-day ER visits, 90-day hospital readmissions, patient-reported outcome measures, and patient satisfaction scores.

NCT ID: NCT05399186 Completed - Clinical trials for Postoperative Complications

Arthroplasty and Modifiable Risk Factors

Start date: August 20, 2018
Phase: N/A
Study type: Interventional

Hip and knee total joint arthroplasty are one of the most frequently performed surgery worldwide. However, prosthetic joint infection remains a devastating complication of them, associated with severe morbidity, increased mortality and huge costs. Several underlying medical conditions that have been identified as independent risk factors for development of prosthetic joint infection. The hypothesis of the study is that by utilizing the waiting time for operation (6 -12 months) to improve the state of known modifiable risk factors the frequency of prosthetic joint infection may be decreased. This optimization was established with co-operation between hospital and primary care. Therefore a prospective non-randomized quality control study before and after an intervention regarding preoperative preparation for total joint arthroplasty of either hip or knee was planned. The control arm was included one week prior to surgery at the anesthesia preoperative assessment outpatient clinic and were operated on between 27/8 2018 and 7/9 2020 and consists of 738 patients. Inclusion of the interventional arm happened at the orthopedic outpatient clinic from 2/1 2019 - 30/1 2021, 6 -12 months prior to surgery and an appointment with their general physician ensured within 3 weeks for further evaluation. Enlisted have been 1010 patients, operation of them started 25/3 2019 and to date 710 patients have been operated on, but due to delays caused by Covid-19 (SARS-CoV-2) surgery of them is still ongoing. The effect of the intervention will be evaluated with by comparison of patient characteristics and frequency of surgical site and prosthetic joint infections before and after.

NCT ID: NCT05369325 Completed - Clinical trials for Total Joint Arthroplasty

Non-invasive Hemoglobin Monitoring in Outpatient Total Joint Arthroplasty

Start date: June 15, 2022
Phase:
Study type: Observational

This research is being done to better understand the accuracy of noninvasive hemoglobin tests on patients that recently underwent total joint arthroplasty.

NCT ID: NCT05286515 Completed - Clinical trials for Total Joint Arthroplasty

A Pilot Study to Test the Feasibility of a Hybrid Preoperative Physical Therapy Intervention for Patients Undergoing Total Joint Arthroplasty

Start date: March 29, 2022
Phase: N/A
Study type: Interventional

This study aims to determine the feasibility of implementing a hybrid physical therapy intervention prior to total joint replacement surgery.

NCT ID: NCT05159739 Enrolling by invitation - Clinical trials for Total Joint Arthroplasty

Genetic Susceptibility to Periprosthetic Joint Infections

Start date: March 7, 2018
Phase:
Study type: Observational

The investigators primary objective is to identify genetic factors that may increase the risk of patients developing a periprosthetic joint infections (PJI) following total joint arthroplasty (TJA). The investigators hope that by identifying genetic predispositions we will be able to provide patient specific care pathways to prevent or minimize the risk for PJI.

NCT ID: NCT04592302 Enrolling by invitation - Smoking Clinical Trials

The Impact of Smoking on Outcomes and Complications in Total Joint Arthroplasty: A Prospective Crossover Study

Start date: December 1, 2016
Phase:
Study type: Observational

The purpose of this study is to examine the impact of smoking cessation on total joint arthroplasty patients with respect to perioperative complications and outcomes. The investigators will examine patients who are asked to stop smoking in any manner they choose and also refrain from nicotine replacement therapy, and those who are allowed to continue smoking during the perioperative period for their total knee or total hip replacement.

NCT ID: NCT04590742 Enrolling by invitation - Sleep Disturbance Clinical Trials

Randomized Trial Investigating Melatonin Supplementation vs Placebo on Sleep Disturbance Following Total Joint Arthroplasty

Start date: February 27, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether melatonin when used as a supplement after surgery improves sleep following total joint arthroplasty

NCT ID: NCT04574752 Enrolling by invitation - Clinical trials for Staphylococcus Aureus

MSSA and MRSA Screening in Patients Undergoing Elective TJA: the Benefits of Next-generation Sequencing

Start date: August 30, 2020
Phase:
Study type: Observational

The aims of this study were to evaluate the diagnostic performance of molecular and culture techniques in S. aureus screening using paired nasal and groin swabs, to determine, if any, discrepancy between the diagnostic techniques and to model the potential effect of different diagnostic techniques on S. aureus detection in orthopaedic patients

NCT ID: NCT04294693 Recruiting - Clinical trials for Total Joint Arthroplasty

Total Joint Arthroplasty in a Pediatric Population

Start date: June 3, 2019
Phase:
Study type: Observational

The primary purpose of this study is to examine the functional ability and quality of life in those patients who received a total joint arthroplasty (TJA) for reasons other than having a solid tumor at the location of the joint.